Sepsis Treatment Inactivates Endotoxins Using Molecules Derived From Chitosan Derivative
Purdue University researchers have developed a novel treatment for septicemia involving molecules derived from chitosan. Chitosan is a linear carbohydrate with many commercial and biomedical uses. This treatment inactivates endotoxins, which are toxins associated with certain types of bacteria and stimulates cytokine release (part of the body's inflammatory response that causes swelling and high fever). This new chitosan shows many advantages over current IV treatments for septicemia. This technology can be used to filter endotoxins out of plasmid DNA samples and filter bacteria from water, making contaminated water samples safe to drink.
Stronger affinity for inactivating endotoxinsExcellent biocompatibility upon injection Lower potential to cause hemolysis, complement activation, and inflammatory responsesCan filter endotoxins out of plasmid DNA samples and remove bacteria from water
Medical/HealthSepsis treatmentContaminant removal from drinking water
Yoon YeoYeo LabPurdue Industrial and Physical Pharmacy
United States
None
美國
